{"id":398574,"date":"2020-12-12T09:10:18","date_gmt":"2020-12-12T14:10:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=398574"},"modified":"2020-12-12T09:10:18","modified_gmt":"2020-12-12T14:10:18","slug":"alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","title":{"rendered":"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN"},"content":{"rendered":"

<\/p>\n

Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN <\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nHalper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share is fair to Alexion shareholders.\n<\/p>\n

\nHalper Sadeh encourages Alexion shareholders to click here to learn more about their legal rights and options<\/a><\/b><\/span> or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com<\/a> or zhalper@halpersadeh.com<\/a>.\n<\/p>\n

\nThe investigation concerns whether Alexion and its board of directors violated the federal securities laws and\/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Alexion shareholders; (2) determine whether AstraZeneca is underpaying for Alexion; and (3) disclose all material information necessary for Alexion shareholders to adequately assess and value the merger consideration. On behalf of Alexion shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.\n<\/p>\n

\nHalper Sadeh encourages Alexion shareholders to click here to learn more about their legal rights and options<\/a><\/b><\/span> or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com<\/a> or zhalper@halpersadeh.com<\/a>.\n<\/p>\n

\nHalper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.\n<\/p>\n

\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201212005017\/en\/<\/a><\/span><\/p>\n

\nHalper Sadeh LLP
\n
Daniel Sadeh, Esq.
\n
Zachary Halper, Esq.
\n
(212) 763-0060
\n
sadeh@halpersadeh.com
\n<\/a>
zhalper@halpersadeh.com
\n<\/a>
https:\/\/www.halpersadeh.com<\/a><\/p>\n

KEYWORDS:<\/b> New York United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share is fair to Alexion shareholders. Halper Sadeh encourages Alexion shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Alexion and its board of directors violated the federal securities laws … <\/p>\n

Continue reading “Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-398574","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAlexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share is fair to Alexion shareholders. Halper Sadeh encourages Alexion shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Alexion and its board of directors violated the federal securities laws … Continue reading "Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-12T14:10:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN\",\"datePublished\":\"2020-12-12T14:10:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"},\"wordCount\":349,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\",\"name\":\"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-12T14:10:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN - Market Newsdesk","og_description":"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share is fair to Alexion shareholders. Halper Sadeh encourages Alexion shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Alexion and its board of directors violated the federal securities laws … Continue reading \"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-12T14:10:18+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN","datePublished":"2020-12-12T14:10:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"},"wordCount":349,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","name":"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-12T14:10:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201212005017r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alexion-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-alexion-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 ALXN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=398574"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398574\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=398574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=398574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=398574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}